FdaApplication
BLA 761385
Identifiers
- fda_app_no: BLA761385
Properties
| Property | Value |
|---|---|
| applicant_name | Teva Pharmaceuticals, Inc. |
| application_type | BLA |
| approval_date | 2026-03-27 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PONLIMSI | DENOSUMAB-ADET | 60MG/ML | Injection |
1 product